Can PET/CT be used more effectively in pleural effusion evaluation?
18F-FDG-PET
CT
Combined approaches
Pleural effusion
Journal
Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
13
04
2021
accepted:
10
06
2021
pubmed:
25
6
2021
medline:
15
12
2021
entrez:
24
6
2021
Statut:
ppublish
Résumé
Sometimes, characterization of pleural effusion (PE) can be challenging especially in patients whom invasive procedures/recurrent invasive procedures cannot be performed. The main purpose of the study is to answer this question, Can Sixty-seven patients' None of the Patients who have contraindications for invasive diagnostic methods, and meet the aforementioned criteria may be considered as MPE primarily. On the other hand, if PE SUV
Identifiants
pubmed: 34165683
doi: 10.1007/s11604-021-01155-z
pii: 10.1007/s11604-021-01155-z
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1186-1194Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. Japan Radiological Society.
Références
Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010. https://doi.org/10.1136/thx.2010.136978 .
doi: 10.1136/thx.2010.136978
Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3000 consecutive thoracenteses. Arch Bronconeumol. 2014;50(5):161–5.
doi: 10.1016/j.arbres.2013.11.007
Hallifax RJ, Talwar A, Wrightson JM, et al. State-of-the-art: Radiological investigation of pleural disease. Respir Med. 2017;124:88–99.
doi: 10.1016/j.rmed.2017.02.013
Sun Y, Yu H, Ma J, Lu P. The Role of 18F-FDG PET/ CT Integrated imaging in distinguishing malignant from benign pleural effusion. PLoS One. 2016. https://doi.org/10.1371/journal.pone.0161764 .
doi: 10.1371/journal.pone.0161764
pubmed: 28036373
pmcid: 5201284
Porcel JM, Hernandez P, Martinez-Alonso M, Bielsa S, Salud A. Accuracy of fluoro deoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. Chest. 2015;147:502–12.
doi: 10.1378/chest.14-0820
Yang MF, Tong ZH, Wang Z, Zhang YY, Xu LL, Wang XJ, et al. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion. Eur J Nucl Med Mol Imaging. 2019;46:1457–67.
doi: 10.1007/s00259-019-04287-7
Kim BS, Kim IJ, Kim SJ, Pak K, Kim K. Predictive Value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients. Onkologie. 2011;34:298–303.
doi: 10.1159/000329612
Nakajima R, Abe K, Sakai S. Diagnostic ability of fdg-pet/ct in the detection of malignant pleural effusion. Medicine. 2015. https://doi.org/10.1097/MD.0000000000001010 .
doi: 10.1097/MD.0000000000001010
pubmed: 26717361
pmcid: 5291602
Alkhawaldeh K, Biersack HJ, Henke A, Ezziddin S. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer. Clin Nucl Med. 2011;36:423–8.
doi: 10.1097/RLU.0b013e3182173823
Arnold DT, De Fonseka D, Perry S, Morley A, Harvey JE, Medford A, et al. Investigating unilateral pleural effusions: the role of cytology. Eur Respir J. 2018;52:1801254.
doi: 10.1183/13993003.01254-2018
Anevlavis S, Kouliatsis G, Sotiriou I, Koukourakis MI, Archontogeorgis K, Karpathiou G, et al. Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration. 2014;87:311–6.
doi: 10.1159/000356764
Chen X, Zhang N, Dong J, Sun G. Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion. Tumor Biol. 2017. https://doi.org/10.1177/1010428317698378 .
doi: 10.1177/1010428317698378
Brun C, Gay P, Cottier M, Karpathiou G, Patoir A, Tiffet O, et al. Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung. Cancer J Thorac Dis. 2018;10(12):6903–11.
doi: 10.21037/jtd.2018.11.127
Zhang X, Duan H, Yu Y, Ma C, Ren Z, Lei Y, et al. Differential diagnosis between benign and malignant pleural effusion with dual energy spectral CT. PLoS One. 2018. https://doi.org/10.1371/journal.pone.0193714 .
doi: 10.1371/journal.pone.0193714
pubmed: 30596787
pmcid: 6312332
Porcel JM, Pardina M, Bielsa S, González A, Light RW. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. Chest. 2015;147(2):513–9.
doi: 10.1378/chest.14-0013
Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J. 2018;48(11):1318–24.
doi: 10.1111/imj.13991